Decentralized Clinical Trials (DCTs)
Inspired by Patients. Powered by Data. Securely Delivered to Scale.
Gain access to the most comprehensive decentralized clinical trial solution built from an ecosystem of tools, people, and processes that let patients, sites, and sponsors participate, contribute to, and monitor any clinical trials outside of a traditional investigative setting.
One Platform for Everyone
By unifying data capture tools and analytics on one platform, sponsors can access real-time intelligence into trial performance and data quality.
One Solution For Sites
With sites and patients on the same platform, sites have access to one system to view all patient data, eliminating the need for multiple applications and logins.
One Intuitive User Experience
A single intuitive dashboard for all clinical trial activities enhances the patient experience, while providing patients with a choice in how they participate.
An End-to-End DCT Solution
Patient Engagement in Clinical Trials
Patient Cloud is a suite of dynamic, patient-centric solutions that empowers people with choice so you can virtually recruit inclusive and diverse participants, keep them engaged throughout your trial, and produce better study results, and ultimately enhance the participant’s experience.
Remote Monitoring and Data Quality Oversight
DCTs present opportunities and challenges for clinical data collection and analysis. Medidata solves these challenges with capabilities for centralized, remote, and risk-based monitoring all on top of a unified data platform. Now you can take a flexible approach to clinical trial monitoring and data quality oversight, shifting from 100% on-site to remote activities, without sacrificing timelines, cost, or data quality.
Ease and Flexibility to Execute Direct-to-Patient (DtP) in Real-time
Rave RTSM has unsurpassed DtP capabilities giving sponsors and CROs the highest level of flexibility for decentralized and hybrid clinical trials. DtP can be enabled for any combination of sites and visits and provides sites the ability to determine the source of the patient’s dispensation.
In addition, patients confirm incoming shipments of IP using their myMedidata account.
DCT Strategic Design Methodology
Decentralized clinical trials are transforming clinical research by delivering better patient experiences and accelerating drug development. But where do you start?
Our Advisory Services team acts as your personal industry expert in designing and operationalizing your DCT strategies.We take an end-to-end approach by combining the organizational and operational aspects of DCTs to ensure a comprehensive end to end solution. Our goal is to design for both current and future states with the sponsor, patient, and site at the forefront.
What You Need to Know About DCTs
The Medidata Decentralized Clinical Trials Program
The Medidata DCT Program is a scalable, flexible, and comprehensive technology solution to virtualize as much or as little of a clinical trial as needed, including patient participation, data capture and management, monitoring and analysis, and supply dispensation
Established DCT Network of Sites
Medidata’s partnership with Circuit Clinical provides a turnkey solution that enhances patient access and inclusion through site ratings and a national network of decentralized clinical trial sites — all trained and certified on Medidata technology.
Decentralized Clinical Trials: The Future of Clinical Research is Here
Read about the changing landscape around decentralized clinical trials and the types of solutions used to run DCTs
Clinical Operations and Decentralized Clinical Trials
Medidata explains the industry’s move towards risk-based quality management (RBQM) approaches to ensure data oversight for DCTs. Discover the value such approaches bring to sponsors, CROs, sites, and ultimately patients.
Decentralized Clinical Trial Resources
The Value of Decentralized Clinical Trials
The world of clinical research has seen a pronounced shift in how clinical trials are conducted. Hear from Anthony Costello, CEO of Patient Cloud at Medidata, as he discusses with Harvard Business Review what DCTs mean for patients, doctors, and pharmaceutical companies.
The Power of Decentralized Clinical Trials
How do today’s clinical trial technologies affect stakeholders involved in clinical research? Hear from Kelly McKee, VP of Patient Registries & Recruitment at Medidata, as she discusses how decentralized trials improve patient, site, and sponsor experiences on the Pivot Points podcast.
Decentralized Clinical Trial Assessment Tool
How comprehensive is your decentralized clinical trial strategy? Find out using our DCT assessment tool.
Decentralized Clinical Trials: Book of Case Studies
Today’s technologies let patients remotely engage with trial activities, creating better patient experiences and letting sponsors execute faster trials driven by high-quality data. Learn how our end-to-end DCT solutions support the patient, site, and sponsor across the entire trial.
What Are Decentralized Clinical Trials?
Find the most frequently asked questions and answers on what decentralized clinical trials mean.